Northern Trust’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-169,937
| Closed | -$9.35M | – | 4824 |
|
|
2022
Q2 | $9.35M | Buy |
169,937
+132,187
| +350% | +$7.27M | ﹤0.01% | 2082 |
|
|
2022
Q1 | $1.21M | Sell |
37,750
-962
| -2% | -$30.8K | ﹤0.01% | 3344 |
|
|
2021
Q4 | $842K | Sell |
38,712
-118
| -0.3% | -$2.57K | ﹤0.01% | 3604 |
|
|
2021
Q3 | $851K | Buy |
38,830
+270
| +0.7% | +$5.92K | ﹤0.01% | 3601 |
|
|
2021
Q2 | $750K | Buy |
38,560
+20,074
| +109% | +$390K | ﹤0.01% | 3601 |
|
|
2021
Q1 | $319K | Sell |
18,486
-13,152
| -42% | -$227K | ﹤0.01% | 3961 |
|
|
2020
Q4 | $507K | Sell |
31,638
-3,842
| -11% | -$61.6K | ﹤0.01% | 3722 |
|
|
2020
Q3 | $379K | Buy |
35,480
+743
| +2% | +$7.94K | ﹤0.01% | 3671 |
|
|
2020
Q2 | $421K | Buy |
+34,737
| New | +$421K | ﹤0.01% | 3598 |
|